Track Sanara MedTech's other current liabilities ($11M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), SMTI shows a other current liabilities of $11M. That compares with $13M in the prior-year period — down 18.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SMTI's other current liabilities is now $11M (was $13M) — a 18.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sanara MedTech is outperforming or lagging.
Tracking SMTI's other current liabilities over time shows whether Sanara MedTech is scaling, shrinking, or reshaping that part of the business. The current reading is $11M That compares with $13M in the prior-year period — down 18.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current liabilities page, Stockcircle has Sanara MedTech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $11M) with ownership activity and broader fundamentals.
Sanara MedTech's other current liabilities is $11M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.